Context Therapeutics Inc banner

Context Therapeutics Inc
NASDAQ:CNTX

Watchlist Manager
Context Therapeutics Inc Logo
Context Therapeutics Inc
NASDAQ:CNTX
Watchlist
Price: 2.64 USD 0.76% Market Closed
Market Cap: $242.6m

Intrinsic Value

CNTX doesn't have a meaningful market cap.

The intrinsic value for Context Therapeutics Inc (CNTX) under the Base Case is 0.24 USD. Compared with the current market price of 2.64 USD, the stock appears Overvalued by 91%.

CNTX Intrinsic Value
0.24 USD
Overvaluation 91%
Intrinsic Value
Price $2.64
Base Case Scenario
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value $0.19
Get notified when the price drops into your buy zone
Current Price $2.64
Intrinsic Value $0.24
Margin of Safety 20% $0.19
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about CNTX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CNTX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Context Therapeutics Inc.

Explain Valuation
Alternatives to CNTX

Wall St
Price Targets

Dividends

Context Therapeutics Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

CNTX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CNTX stock?

The intrinsic value for Context Therapeutics Inc (CNTX) under the Base Case is 0.24 USD.

Is CNTX stock undervalued or overvalued?

Compared with the current market price of 2.64 USD, the stock appears Overvalued by 91%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett